Feasibility, Phase I, and Pharmacological Study of Aerosolized Liposomal 9‐Nitro‐20(S)‐Camptothecin in Patients with Advanced Malignancies in the Lungs
- 1 December 2000
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 922 (1) , 352-354
- https://doi.org/10.1111/j.1749-6632.2000.tb07063.x
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- 9‐Nitrocamptothecin Liposome Aerosol Treatment of Human Cancer Subcutaneous Xenografts and Pulmonary Cancer Metastases in MiceAnnals of the New York Academy of Sciences, 2000
- Tolerance of Volunteers to Cyclosporine A-dilauroylphosphatidylcholine Liposome AerosolAmerican Journal of Respiratory and Critical Care Medicine, 1997
- DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in XenograftsScience, 1989